| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Immunology | 117 | 59 | 55 | 15 |
| Medicine | 2262 | 26 | 26 | 11 |
The scientific interests tackled in the journal are Antibody, Monoclonal antibody, Immunology, Antigen and Molecular biology. Topics in Antibody explored in it were investigated in conjunction with research in Cell biology, Biochemistry, Computational biology and Virology. The Cell biology study featured in it draws connections with the study of Receptor.
Most of the Computational biology studies addressed also intersect with Antibody fragments. It centers on topics in Virology, with a focus on Virus. Issues in Monoclonal antibody were discussed, taking into consideration concepts from other disciplines like Cancer, Cancer research, Phage display and Recombinant DNA.
While Cancer research is the key highlight in it, it also covered some subjects on In vivo and In vitro. Antibodies primarily discusses Immunology topics, particularly Immune system, Autoantibody, Autoimmunity, B cell and Antibody-dependent cell-mediated cytotoxicity. The work on Immune system presented in the journal focuses on Immunotherapy in particular.
The published papers mainly tackle studies in Antibody, Monoclonal antibody, Immunology, Immune system and Computational biology. The most cited papers explore issues in Antibody which can be linked to other research areas like Virology, Antigen, Molecular biology, Drug and Effector. While Monoclonal antibody is the focus of the published articles, it also provides insights into the studies of Recombinant DNA, In vivo and Immunotherapy.
Antibodies facilitates discussions on Antibody, Monoclonal antibody, Immunology, Epitope and Drug. While work presented in the journal provided substantial information on Antibody, it also covered topics in Immunohistochemistry, Internal medicine, Antigen, Molecular biology and Cell biology. While Monoclonal antibody is the focus of it, it also provided insights into the studies of Pharmacokinetics, In vitro, Mutagenesis, Recombinant DNA and Characterization (materials science).
In addition to Epitope research, the journal aims to explore topics under Amino acid, Biochemistry, Peptide and Neutralizing antibody, Immune system. Antibodies tackles studies in Mammary tumor and the interrelated subject of Receptor to gain insights into Immune system. While the journal focused on Drug, it was also able to explore topics like Computational biology, Small molecule, Clinical pharmacology and Drug discovery.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Antibodies (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Antibodies (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 28.21% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 17.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 17.86% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 35.71% of all publications and 28.57% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
David Zahavi;Louis Weiner
(2020)Rena Liu;Robert J. Oldham;Emma Teal;Stephen A. Beers
(2020)Souad Boune;Peisheng Hu;Alan L Epstein;Leslie A Khawli
(2020)Margot Revel;Marie V. Daugan;Catherine Sautés-Fridman;Wolf H. Fridman
(2020)Josée Golay;Ronald P. Taylor
(2020)Zheng Cai;Mark I. Greene;Zhiqiang Zhu;Hongtao Zhang
(2020)For those interested in Medicine in the USA, exploring related online degrees can provide valuable flexibility and cost-effective education options. Nursing, in particular, offers diverse pathways that complement medical knowledge and expand career opportunities.
Many students start by pursuing affordable programs such as the cheapest accelerated nursing programs, which allow for a faster transition into nursing roles. For those looking to enhance their qualifications remotely, the best online rn to bsn programs provide a solid foundation in nursing practice with the convenience of online learning.
Advancing further, nurses can pursue specialized degrees such as the Doctor of Nursing Practice (DNP). The cheapest online bsn to dnp programs offer accessible routes for bachelor's degree holders aiming to achieve doctoral-level expertise and leadership roles.
For career advancement into clinical practice beyond traditional nursing roles, the cheapest online nurse practitioner programs provide rigorous training that prepares graduates to work independently in specialized medical fields.
Exploring these online programs can be a strategic step for anyone looking to broaden their medical career prospects without compromising affordability or quality.
